Supplementary Figure S2 from Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity

2026 Open access

Read full text
Authors: Chakrapani Tripathi, Sergey N. Zolov, John Nguyen, Frank Luh, Venkatesh Natarajan, Yun Yen
DOI: 10.1158/2767-9764.31645570
Cited by: 0

Abstract

Figure S2. CLL-1 nanobodies clones screening in Human T cells

Fields of Study & Subjects

CAR-T cell therapy research Chronic Lymphocytic Leukemia Research T-cell and B-cell Immunology

Publication details

Publication date
11 March 2026
Language
EN